tiprankstipranks
Trending News
More News >
Strategic Pivot and Promising Trials: Shattuck Labs’ Growth Potential in IBD with SL-325
PremiumRatingsStrategic Pivot and Promising Trials: Shattuck Labs’ Growth Potential in IBD with SL-325
2M ago
Shattuck Labs’ SL-325: Promising Preclinical Results and Growth Potential Justify Buy Rating
Premium
Ratings
Shattuck Labs’ SL-325: Promising Preclinical Results and Growth Potential Justify Buy Rating
2M ago
Shattuck Labs: Hold Rating Due to Early Pipeline Stages and Lack of Near-Term Catalysts
Premium
Ratings
Shattuck Labs: Hold Rating Due to Early Pipeline Stages and Lack of Near-Term Catalysts
2M ago
Shattuck Labs’ SL-325 shows positive results in inflammatory bowel disease
PremiumThe FlyShattuck Labs’ SL-325 shows positive results in inflammatory bowel disease
3M ago
Shattuck Labs highlights upcoming key milestones in 2025
Premium
The Fly
Shattuck Labs highlights upcoming key milestones in 2025
5M ago
Shattuck Labs Focuses on Promising Antibody Development
Premium
Company Announcements
Shattuck Labs Focuses on Promising Antibody Development
6M ago
Shattuck Labs downgraded to Neutral from Buy at Citi
PremiumThe FlyShattuck Labs downgraded to Neutral from Buy at Citi
8M ago
Shattuck Labs downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Shattuck Labs downgraded to Neutral from Buy at H.C. Wainwright
8M ago
Shattuck Labs Refocuses Strategy Amidst Restructuring and Cuts
Premium
Company Announcements
Shattuck Labs Refocuses Strategy Amidst Restructuring and Cuts
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100